AVAIOTCServices-Computer Processing & Data PreparationFiscal year ends March 31
AVAI BIO, INC.
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.11−0.00 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $17.24M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Avai Bio has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Avai Bio filed with the SEC
LETTER OF INTENT, DATED AS OF JUNE 3, 2024
Other events · EX-99.1 to Form 8-K
PRESS RELEASE, DATED JUNE 5, 2024
Other events · EX-99.2 to Form 8-K